FR2327764A1 - Nouvelles compositions pharmaceutiques et leur preparation - Google Patents
Nouvelles compositions pharmaceutiques et leur preparationInfo
- Publication number
- FR2327764A1 FR2327764A1 FR7630866A FR7630866A FR2327764A1 FR 2327764 A1 FR2327764 A1 FR 2327764A1 FR 7630866 A FR7630866 A FR 7630866A FR 7630866 A FR7630866 A FR 7630866A FR 2327764 A1 FR2327764 A1 FR 2327764A1
- Authority
- FR
- France
- Prior art keywords
- preparation
- pharmaceutical compositions
- new pharmaceutical
- new
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2327764A1 true FR2327764A1 (fr) | 1977-05-13 |
FR2327764B1 FR2327764B1 (bg) | 1979-03-02 |
Family
ID=5959411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7630866A Granted FR2327764A1 (fr) | 1975-10-17 | 1976-10-14 | Nouvelles compositions pharmaceutiques et leur preparation |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS5854122B2 (bg) |
AT (1) | AT362510B (bg) |
AU (1) | AU508628B2 (bg) |
BE (1) | BE847368A (bg) |
CA (1) | CA1079641A (bg) |
CH (1) | CH643737A5 (bg) |
CS (1) | CS199647B2 (bg) |
DE (1) | DE2546577B2 (bg) |
DK (1) | DK146194C (bg) |
ES (1) | ES452420A1 (bg) |
FI (1) | FI762875A (bg) |
FR (1) | FR2327764A1 (bg) |
GB (1) | GB1560406A (bg) |
GR (1) | GR61268B (bg) |
HK (1) | HK3183A (bg) |
HU (1) | HU172533B (bg) |
IE (1) | IE43778B1 (bg) |
IL (1) | IL50686A (bg) |
MY (1) | MY8400063A (bg) |
NL (1) | NL184558C (bg) |
NO (1) | NO144468C (bg) |
NZ (1) | NZ182341A (bg) |
PH (1) | PH14513A (bg) |
PT (1) | PT65719B (bg) |
SE (1) | SE430379B (bg) |
SG (1) | SG63082G (bg) |
SU (1) | SU1165223A3 (bg) |
ZA (1) | ZA766166B (bg) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2454804A1 (fr) * | 1979-04-26 | 1980-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
FR2508313A1 (fr) * | 1981-06-24 | 1982-12-31 | Sandoz Sa | Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation |
EP0277092A1 (de) * | 1987-01-14 | 1988-08-03 | Ciba-Geigy Ag | Therapeutisches System für schwerlösliche Wirkstoffe |
FR2610827A1 (fr) * | 1987-02-18 | 1988-08-19 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
EP0664131A1 (de) * | 1994-01-21 | 1995-07-26 | Krewel Meuselbach GmbH | Optimal freisetzende Kava-Extrakte |
WO2001039742A2 (en) * | 1999-12-03 | 2001-06-07 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
CH642259A5 (de) * | 1978-12-21 | 1984-04-13 | Sandoz Ag | Galenische zubereitungen fuer orale applikation von ergotalkaloiden. |
US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
IL136460A0 (en) * | 1997-12-22 | 2001-06-14 | Schering Corp | Molecular dispersion composition with enhanced bioavailability |
US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
PT1638527E (pt) * | 2003-06-27 | 2007-02-28 | Bioprogress Spa | Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2454804A1 (fr) * | 1979-04-26 | 1980-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
FR2508313A1 (fr) * | 1981-06-24 | 1982-12-31 | Sandoz Sa | Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation |
EP0277092A1 (de) * | 1987-01-14 | 1988-08-03 | Ciba-Geigy Ag | Therapeutisches System für schwerlösliche Wirkstoffe |
FR2610827A1 (fr) * | 1987-02-18 | 1988-08-19 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
EP0280613A1 (fr) * | 1987-02-18 | 1988-08-31 | Pierre Fabre Medicament | Comprimé de dihydroergotamine (D.H.E.) du type à matrice hydrophile et son procédé de fabrication |
EP0664131A1 (de) * | 1994-01-21 | 1995-07-26 | Krewel Meuselbach GmbH | Optimal freisetzende Kava-Extrakte |
WO2001039742A2 (en) * | 1999-12-03 | 2001-06-07 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
WO2001039742A3 (en) * | 1999-12-03 | 2001-12-13 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
EP1512403A1 (en) * | 1999-12-03 | 2005-03-09 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2276832A1 (fr) | Nouvelles compositions pharmaceutiques et leur preparation | |
BE839615A (fr) | Nouvelles amidinourees, leur preparation et leur emploi | |
FR2327764A1 (fr) | Nouvelles compositions pharmaceutiques et leur preparation | |
BE853422A (fr) | Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant | |
BE843152A (fr) | Nouvelles cephalosporimes, leur preparation et leur emploi | |
BE832921A (fr) | Nouvelles rifamycines et leur preparation | |
FR2285891A1 (fr) | Nouvelles benzodiazepines et leur preparation | |
BE841797A (fr) | Compositions photosensibles et leur application | |
FR2320745A1 (fr) | Nouveaux agents anti-flammatoires imidazoles, leur preparation et compositions pharmaceutiques | |
BE847165A (fr) | Nouvelles compositions detergentes et leur preparation, | |
BE871857A (fr) | Nouvelles piperazines disubstituees, leur procedes de preparation et les compositions pharmaceutiques les renfermant | |
BE825982A (fr) | Triazoloquinazolines et leur preparation | |
FR2276833A1 (fr) | Nouvelles compositions galeniques et leur preparation | |
BE844029A (fr) | Diepoxy-androstanes et leur preparation | |
FR2310132A1 (fr) | 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant | |
FR2313059A1 (fr) | Nouvelles solutions pharmaceutiques stables et leur preparation | |
FR2340310A1 (fr) | Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant | |
BE869560R (fr) | Nouvelles solutions pharmaceutiques stables et leur preparation | |
FR2275207A1 (fr) | Nouvelles benzylamines leur preparation et les compositions pharmaceutiques en contenant | |
BE846502A (fr) | Agents antimicrobiens et leur preparation | |
BE826925A (fr) | Nouvelles pyrrolodiazepines et leur preparation | |
BE840608A (fr) | Nouvelles compositions pharmaceutiques | |
BE820256A (fr) | Nouvelles phenoxyalkylamines et leur preparation | |
FR2287220A1 (fr) | Nouvelles compositions pharmaceutiques anti-inflammatoires et leur procede de preparation | |
FR2313358A1 (fr) | Urethanne-polythiols et leur preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |